Dynamic monitoring serum tumor markers to predict molecular features of EGFR-mutated lung cancer during targeted therapy.
Chen Z, Liu L, Zhu F, Cai X, Zhao Y, Liang P, Ou L, Zhong R, Yu Z, Li C, Li J, Xiong S, Feng Y, Cheng B, Liang H, Xie Z, Liang W, He J.
Chen Z, et al. Among authors: liang p, liang w, liang h.
Cancer Med. 2022 Aug;11(16):3115-3125. doi: 10.1002/cam4.4676. Epub 2022 May 11.
Cancer Med. 2022.
PMID: 35543090
Free PMC article.